January 30 – February 1, 2023 | London

Harness the excitement following the first ever allogeneic commercial approval which was achieved in Europe last month at the 2nd Allogeneic Cell Therapies Summit Europe. Come together with the community pioneering off-the-shelf success and gain insights from industry leaders including Atara Biotherapeutics, Leucid Bio, Pluri, Gasdeta, Karolinska Institute, and many more.

Don’t miss the 23+ industry experts, sharing approaches to enhance potency and persistence to drive durability, scale-up manufacturing and cryopreservation to improve accessibility, optimise donor selection, prevent immunogenicity and discuss European regulations to accelerate development from discovery to commercialisation.

Register today to join the Beacon team as we come together to unlock the optimal donor, and boost manufacturing scalability.